Medical research funding is crucial for advancing healthcare, yet recent funding cuts have posed significant challenges to the integrity of research designed to protect patient safety.The freeze on more than $2 billion in federal grants has disrupted important oversight mechanisms administered by institutional review boards (IRBs), jeopardizing the ethical conduct of clinical studies.